| First Author | Pinto M | Year | 2013 |
| Journal | Neurobiol Aging | Volume | 34 |
| Issue | 10 | Pages | 2399-2407 |
| PubMed ID | 23702344 | Mgi Jnum | J:211726 |
| Mgi Id | MGI:5576092 | Doi | 10.1016/j.neurobiolaging.2013.04.014 |
| Citation | Pinto M, et al. (2013) Mitochondrial DNA damage in a mouse model of Alzheimer's disease decreases amyloid beta plaque formation. Neurobiol Aging 34(10):2399-2407 |
| abstractText | Mitochondrial DNA (mtDNA) damage and the generation of reactive oxygen species have been associated with and implicated in the development and progression of Alzheimer's disease. To study how mtDNA damage affects reactive oxygen species and amyloid beta (Abeta) pathology in vivo, we generated an Alzheimer's disease mouse model expressing an inducible mitochondrial-targeted endonuclease (Mito-PstI) in the central nervous system. Mito-PstI cleaves mtDNA causing mostly an mtDNA depletion, which leads to a partial oxidative phosphorylation defect when expressed during a short period in adulthood. We found that a mild mitochondrial dysfunction in adult neurons did not exacerbate Abeta accumulation and decreased plaque pathology. Mito-PstI expression altered the cleavage pathway of amyloid precursor protein without increasing oxidative stress in the brain. These data suggest that mtDNA damage is not a primary cause of Abeta accumulation. |
